A Bengali Dietary Salt Study to Control Blood Pressure

A Multi-method Study of a Low-salt Dietary Approach to Control Blood Pressure in the Bangladeshi Chronic Kidney Disease Population.

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00702312

Enrollment

Registered

2008-06-20

Start date

2008-06-30

Completion date

2009-07-31

Last updated

2009-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Blood pressure

Brief summary

The aim of this study is to assess the benefits of using low-salt and healthy eating educational programme, designed specifically for Bangladeshi kidney patients, compared to the usual diet advice given by the clinic dietitians.

Detailed description

We conducted an exploratory study initially to learn about the East London Bangladeshi (ELB) kidney patients salt intake. Furthermore, we assessed their educational needs to inform the development and implementation of an educational programme to reduce dietary salt intake in line with the Department of Health recommendations for a good blood pressure control. The educational programme will be tested in a randomized controlled trial. We are interested in salt because studies have shown that salt is one of the causes of high blood pressure. Scientific studies have also shown that the longer a person has high blood pressure the more the damage to the kidneys.

Interventions

BEHAVIORALLow-salt educational programme

Subjects will attend a health promotion cooking programme and receive written tailored low-salt Bengali educational tool. This tool has been developed specifically for this population group from Phase 1 and 2 study.

BEHAVIORALLow-salt Bangladeshi educational programme

A multi-component low-salt educational programme tailored to the Bangladeshi kidney disease patients delivered in the community.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Adult Bengali kidney disease hypertensive patients

Exclusion criteria

* Non-hypertensive Bengali patients and those on dialysis therapy

Design outcomes

Primary

Measure	Time frame
Reduction in blood pressure	Six months

Secondary

Measure	Time frame
Reduction in dietary salt intake	Six months

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026